Source: International Congress 2018 – Challenges in tuberculosis care
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. da Silva Alcobia (Coimbra, Portugal), L. Nogueira (Coimbra, Portugal), M. Villar (Lisboa, Portugal), C. Robalo Cordeiro (Coimbra, Portugal), C. Fontes Ribeiro (Coimbra, Portugal), F. Regateiro (Coimbra, Portugal), H. Coimbra Silva (Coimbra, Portugal). Precision medicine in tuberculosis treatment – a role for pharmacogenetics?. 2689

Member's Comments

No comment yet.

Related content which might interest you: Will clinicians keep their place in modern management of tuberculosis? Source: Eur Respir J 2001; 18: Suppl. 33, 474s Year: 2001 Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Source: Eur Respir J 2013; 42: 1449-1453 Year: 2013 Precision medicine in COPD: where are we and where do we need to go? Source: Eur Respir Rev, 27 (149) 180022; 10.1183/16000617.0022-2018 Year: 2018 Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era Source: Eur Respir Rev, 27 (148) 180004; 10.1183/16000617.0004-2018 Year: 2018 Accelerating tuberculosis elimination in low-incidence settings: the role of genomics Source: Eur Respir J 2015; 46: 1840-1841 Year: 2015 Accelerating tuberculosis elimination in low-incidence settings: the role of genomics Source: Eur Respir J 2015; 46: 1841-1843 Year: 2015 What is the role of genetics in occupational asthma? Source: Eur Respir J 2009; 33: 459-460 Year: 2009 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 In the era of personalized medicine, what are the current unmet needs in asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020 Year: 2021 Asthma susceptibility: from pathophysiology to personalised medicine Source: International Congress 2015 – ME4 Asthma susceptibility Year: 2015 Precision medicine in airway diseases: moving to clinical practice Source: Eur Respir J, 50 (4) 1701655; 10.1183/13993003.01655-2017 Year: 2017 Fate or missed opportunities - challenges in diagnosing paediatric drug resistant tuberculosis in Germany Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 The role of patients in medicine Source: Virtual Congress 2020 – The role of patients in medicine Year: 2020 What role can medical professionals play in the development and regulation of medical technology? Source: Research Seminar 2015 - Personalising respiratory care in Europe Year: 2015 What is the role of oral corticosteroids in the era of biologics in asthma? Source: International Congress 2019 – State of the art session: Airway disease Year: 2019